Amino Chemicals

Amino Chemicals
Amino Chemicals

About Organization

Amino Chemicals Limited, strategically located in the Marsa Industrial Estate of Malta, is a highly specialized European manufacturer of premium Active Pharmaceutical Ingredients (APIs). Operating as a key subsidiary of the globally renowned Italian Dipharma Group, Amino Chemicals benefits from deep financial backing, extensive R&D synergies, and a robust global distribution network.

The company focuses primarily on the development and production of complex generic APIs and advanced pharmaceutical intermediates. Their strategic location in Malta offers significant intellectual property advantages, allowing them to develop non-infringing manufacturing processes and launch high-quality generic molecules into the European and global markets immediately upon patent expiry.

Amino Chemicals boasts a highly modern, fully compliant cGMP manufacturing facility that is routinely inspected and approved by leading global health authorities, including the EU EMA and the US FDA. The company excels in multi-step organic chemical synthesis, handling complex reactions with a strong emphasis on process optimization, high yield, and extreme purity.

Their product portfolio supports various therapeutic areas, including neurology, cardiovascular diseases, and metabolic disorders. Furthermore, as part of the Dipharma network, Amino Chemicals is deeply integrated into a culture of strict safety, environmental responsibility, and continuous scientific training. Their ability to deliver European-quality APIs with a highly agile and responsive supply chain makes them a preferred partner for generic pharmaceutical formulators worldwide.

Organization Type
Private Company
Products / Services Offered
APIs, Advanced Intermediates
Certifications
EU GMP, US FDA

Research & Innovation

Research Highlights
Optimization of multi-step API chemical synthesis.
Publications & Research Output
Focuses on proprietary non-infringing processes for generics.

Enterprise Profile

Research Facilities
EU-based GMP manufacturing site in Malta.
Leadership Team
Marc-Olivier Geinoz (CEO of Dipharma Group)
Strategic Partnerships
Integrated within Dipharma Francis global network.

Contact Information

Address
MRA 050X, Marsa Industrial Estate, Marsa, MRS 3000, Malta
Social Info

Location

Organization Tags